x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

science life sciences

All Episodes

58:18

The VC Biotech investor

Molecule to Market: Inside the outsourcing space ·

2024/09/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Garabedian, CEO at Xontogeny and Venture Fund Manager at Perceptive Advisors.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering: How he utilized his pharma experience to become a CEO and revitalize a biotech company, positioning it for a $15bn market cap Why the biotech space had such a market downturn, and how the

en

44:57

The diamond in the rough

Molecule to Market: Inside the outsourcing space ·

2024/09/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kent Payne, CEO at Aliri Bioanalysis.Your host Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kent, covering: Being exposed to scientific efficiencies early on in his career as a bench scientist, and what it took to bring a successful NDA to market The formative years of Catalent, and helping to establish its early biologics and bioanalysis

en

01:02:29

One-hour special - The President of the PBOA

Molecule to Market: Inside the outsourcing space ·

2024/08/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gil, covering: The evolution of the PBOA over the last decade, the impact of M&A on the Association, and building a safe place where CDMOs belong How the industry has evolved over the last few years after

en

56:02

The puzzle-solving CEO

Molecule to Market: Inside the outsourcing space ·

2024/08/23

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steven Chevillotte, Chief Executive Officer at SaniSure.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Steven, covering: Building a great partner through professionalization and integration while retaining founder DNA of entrepreneurship and innovation The transformation of quality components and complex assemblies to game changing

en

22:53

Summer sentiment: A life science industry check-in &...

Molecule to Market: Inside the outsourcing space ·

2024/08/16

In this mid year episode special, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the trends happening across the life sciences and outsourcing space in 2024. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain covering: The anticipated recovery of the biotech sector and where it stands now Geopolitical influences on the life sciences industry, with a focus on the CDMO sector

en

51:47

Pivoting to partnership success in clinical trial

Molecule to Market: Inside the outsourcing space ·

2024/08/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Yussuf Goolam, Co-Founder, President and CEO at RxSource.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Yussuf, covering: His family's journey from Mozambique to North America and the value of having an entrepreneurial ethos Lifelong business lessons from a window cleaning job... and the impact of going on a learning rampage The

en

01:00:24

A Sterling, CDMO leader

Molecule to Market: Inside the outsourcing space ·

2024/08/02

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Cook, CEO at Sterling Pharma Solutions.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kevin, covering: Decades of mixed ownership and conflicting business models led to lots of character-building learnings... and the rebirth of Sterling The power of a rebrand and sense of togetherness to gain commercial traction Kevin’s five-point

en

52:32

AI as a force for good in drug development

Molecule to Market: Inside the outsourcing space ·

2024/07/19

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vijay Vaswani, Co-Founder & CEO at Omniscope.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Vijay, covering: How travel expands the mind and enables you to amplify your network The founding story of Omniscope and its mission of using tech to help unlock the immune system AI can read the immune system in HD, helping with clinical

en

52:32

Harnessing tech to improve the economics of making...

Molecule to Market: Inside the outsourcing space ·

2024/07/05

In this episode of Molecule to Market, you’ll go inside the global drug development and GMP Manufacturing space with David Staunton, Head of Life Sciences Transformation at Cognizant.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering: Why being a supplier is harder if you have not been on the client side An industry driven by change and the importance of digital strategy to drive business outcomes Why pharma companies need to be both

en

34:54

Tasty Topics: Addressing the potential impact of the...

Molecule to Market: Inside the outsourcing space ·

2024/06/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:Tom Willson, Vice President of Contract Manufacturing at Pfizer CentreOne Hanna Lesch, Chief Technology Officer at Extothera Stephen Grant, entrepreneurial advisor and angel investor Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, Hanna, and Stephen, covering: Unraveling the potential seismic shift in the pharmaceutical outsourcing

en

44:56

Becoming...a world class scientific leader

Molecule to Market: Inside the outsourcing space ·

2024/06/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mihaela Simianu, Vice President of R&D and Operations at Singota Solutions.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mihaela, covering: How having physician parents in Romania motivated Mihaela into a career in the biopharmaceutical space What 17 years at Eli Lilly taught her about drug development and

en

55:18

Mission-driven doctor, inventor & entrepreneur

Molecule to Market: Inside the outsourcing space ·

2024/06/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Doctor Eric Edwards, Co-Founder and CEO at Phlow.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Eric, covering: How a life-threatening allergy for him and his identical twin brother led to a career in medicine and then an entrepreneurial journey in the pharma space The journey from inventors to becoming a commercial pharma

en

56:22

The boomerang boy impacting gene therapies

Molecule to Market: Inside the outsourcing space ·

2024/06/07

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andy Holt, CCO of Viralgen Vector Core.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andy, covering: Growing a CDMO while dealmaking in a gene therapy company…at the same time Selling a revenue-generating therapy company to Bayer during the pandemic Faster failure or faster acceleration; the need to celebrate every gene therapy batch as

en

50:58

Taking on the biologics CDMOs from down under

Molecule to Market: Inside the outsourcing space ·

2024/05/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark W. Womack, Chief Executive Officer at BioCina.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mark, covering: How a tough upbringing in LA led him to the US Navy, and then onto a pathway into leadership Why he decided to end his own practice and jump into a senior role within a biopharma CDMO space The key factors that led him to

en

55:04

A true nerd of CGT

Molecule to Market: Inside the outsourcing space ·

2024/05/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bill Vincent, Founder and board chair at Genezen.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Bill, covering: The days when CGT therapies were viewed as just academic... then the events in 2012 that changed everything in the space How partnering with Indiana University for its vector capacity led to the creation of Genezen Building a

en

51:38

The virtual and decentralized clinical trials...

Molecule to Market: Inside the outsourcing space ·

2024/05/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Helen Shaw and Dan Henley, co-founders of VCTC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Helen and Dan, covering: Exposing your team to everything, letting them feel the pressure... but always being there to help and guide The founding story of VCTC... and the fun and games of dividing responsibilities as co-founders How the

en

51:02

Jumping into CDMO after a lifetime as a sponsor

Molecule to Market: Inside the outsourcing space ·

2024/05/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bill Humphries, CEO at Alcami. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Bill, covering: The role managers, leaders, and mentors have played in shaping his illustrious career in dermatology The importance of ‘force multiply’ in getting results and accelerating growth Why, after a career spent on the drug sponsor side... he decided to

en

54:12

Zero to a billion... A CDMO original - part 2

Molecule to Market: Inside the outsourcing space ·

2024/05/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector for part 2 of our conversation with Thomas Eldered, Executive Chairman at Flerie.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: The story behind Recipharm’s decision to divest Cobra Biologics that led Thomas to become owner How ‘big faith’ and the gene therapy revolution changed the fortunes of the loss-making biologics

en

01:04:10

Zero to a billion... A CDMO original - part 1

Molecule to Market: Inside the outsourcing space ·

2024/04/26

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with part 1 of our episode with Thomas Eldered, Executive Chairman at Flerie. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: Where his entrepreneurial spark originated, and how they created a CMO (before that was even a thing) after several failed plans How did the timing of his first exit and having ‘cash during the

en

49:58

Dan’s the man...at Custom Biologics

Molecule to Market: Inside the outsourcing space ·

2024/04/19

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dan Mamelak, Founder & President at Custom Biologics.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dan, covering: How reading The Billion-dollar Molecule book inspired him to explore a pathway into cutting-edge drug development The founding story of his company and some timeless advice not to burn bridges How the Canadian conveyor

en

247 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter